Atli Thorarensen

3.2k total citations · 1 hit paper
45 papers, 2.0k citations indexed

About

Atli Thorarensen is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Atli Thorarensen has authored 45 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Organic Chemistry, 19 papers in Molecular Biology and 8 papers in Pharmacology. Recurrent topics in Atli Thorarensen's work include Asymmetric Synthesis and Catalysis (10 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Cancer therapeutics and mechanisms (4 papers). Atli Thorarensen is often cited by papers focused on Asymmetric Synthesis and Catalysis (10 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Cancer therapeutics and mechanisms (4 papers). Atli Thorarensen collaborates with scholars based in United States, Sweden and Iceland. Atli Thorarensen's co-authors include Scott E. Denmark, Guðmundur G. Haraldsson, Jan‐E. Bäckvall, Donald S. Middleton, Kenichiro Itami, Mark E. Schnute, Jean‐Baptiste Telliez, Christina R. Harris, Matthew J. Pelc and Anna Karlström and has published in prestigious journals such as Chemical Reviews, Journal of the American Chemical Society and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Atli Thorarensen

45 papers receiving 1.9k citations

Hit Papers

Tandem [4+2]/[3+2] Cycloadditions of Nitroalkenes 1996 2026 2006 2016 1996 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tandem [4+2]/[3+2] Cycloadditions of Nitroalkenes
    1996 612 citations Atli Thorarensen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Atli Thorarensen United States 24 1.2k 749 156 123 105 45 2.0k
Gregory P. Roth United States 25 1.2k 0.9× 645 0.9× 182 1.2× 126 1.0× 102 1.0× 64 1.9k
Randall W. Hungate United States 22 748 0.6× 643 0.9× 141 0.9× 109 0.9× 52 0.5× 51 1.4k
R. M. Garbaccio United States 22 1.2k 1.0× 959 1.3× 130 0.8× 182 1.5× 95 0.9× 40 1.9k
Mark E. Schnute United States 19 715 0.6× 618 0.8× 134 0.9× 81 0.7× 53 0.5× 25 1.4k
Todd C. Somers United States 14 707 0.6× 890 1.2× 301 1.9× 108 0.9× 82 0.8× 18 1.6k
Shyam Krishnan United States 15 1.2k 1.0× 838 1.1× 209 1.3× 97 0.8× 112 1.1× 15 1.7k
Johannes D. Aebi Switzerland 24 606 0.5× 1.1k 1.4× 93 0.6× 164 1.3× 67 0.6× 40 1.6k
Jay Wrobel United States 33 1.5k 1.2× 876 1.2× 410 2.6× 177 1.4× 127 1.2× 76 2.8k
J. T. Link United States 21 1.3k 1.1× 593 0.8× 329 2.1× 278 2.3× 83 0.8× 42 2.0k
Nigel Vicker United Kingdom 25 878 0.7× 666 0.9× 92 0.6× 165 1.3× 49 0.5× 48 1.7k

Countries citing papers authored by Atli Thorarensen

Since Specialization
Citations

This map shows the geographic impact of Atli Thorarensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atli Thorarensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atli Thorarensen more than expected).

Fields of papers citing papers by Atli Thorarensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atli Thorarensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atli Thorarensen. The network helps show where Atli Thorarensen may publish in the future.

Co-authorship network of co-authors of Atli Thorarensen

This figure shows the co-authorship network connecting the top 25 collaborators of Atli Thorarensen. A scholar is included among the top collaborators of Atli Thorarensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atli Thorarensen. Atli Thorarensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thorarensen, Atli, Paul Balbo, Mary Ellen Banker, et al.. (2020). The advantages of describing covalent inhibitor in vitro potencies by IC50 at a fixed time point. IC50 determination of covalent inhibitors provides meaningful data to medicinal chemistry for SAR optimization. Bioorganic & Medicinal Chemistry. 29. 115865–115865. 41 indexed citations
2.
Xu, Hua, Michael I. Jesson, Uthpala Seneviratne, et al.. (2019). PF-06651600, a Dual JAK3/TEC Family Kinase Inhibitor. ACS Chemical Biology. 14(6). 1235–1242. 112 indexed citations
3.
Wang, Bu, Brian Juba, Michael L. Vazquez, et al.. (2017). Microfluidic-Enabled Intracellular Delivery of Membrane Impermeable Inhibitors to Study Target Engagement in Human Primary Cells. ACS Chemical Biology. 12(12). 2970–2974. 24 indexed citations
4.
Leung, Louis, Xin Yang, Timothy J. Strelevitz, et al.. (2016). Clearance Prediction of Targeted Covalent Inhibitors by In Vitro-In Vivo Extrapolation of Hepatic and Extrahepatic Clearance Mechanisms. Drug Metabolism and Disposition. 45(1). 1–7. 25 indexed citations
5.
Lovering, Frank, Joseph J. McDonald, Gavin A. Whitlock, et al.. (2012). Identification of Type‐II Inhibitors Using Kinase Structures. Chemical Biology & Drug Design. 80(5). 657–664. 17 indexed citations
6.
Trujillo, John I., James R. Kiefer, Wei Huang, et al.. (2012). Investigation of the binding pocket of human hematopoietic prostaglandin (PG) D2 synthase (hH-PGDS): A tale of two waters. Bioorganic & Medicinal Chemistry Letters. 22(11). 3795–3799. 18 indexed citations
7.
Meyers, Marvin J., Scott A. Long, Matthew J. Pelc, et al.. (2011). Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro[3.5]nonane urea PF-04862853, an orally efficacious inhibitor of fatty acid amide hydrolase (FAAH) for pain. Bioorganic & Medicinal Chemistry Letters. 21(21). 6545–6553. 23 indexed citations
8.
Moore, William, David J. Richard, & Atli Thorarensen. (2010). An analysis of the diaminopyrimidine patent estates describing spleen tyrosine kinase inhibitors by Rigel and Portola. Expert Opinion on Therapeutic Patents. 20(12). 1703–1722. 17 indexed citations
9.
Gierse, James K., Atli Thorarensen, Erica L. Bradshaw‐Pierce, et al.. (2010). A Novel Autotaxin Inhibitor Reduces Lysophosphatidic Acid Levels in Plasma and the Site of Inflammation. Journal of Pharmacology and Experimental Therapeutics. 334(1). 310–317. 181 indexed citations
10.
Meyers, Marvin J., Matthew J. Pelc, Satwik Kamtekar, et al.. (2010). Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding mode. Bioorganic & Medicinal Chemistry Letters. 20(5). 1543–1547. 31 indexed citations
11.
Wang, Jane L., Barbara A. Schweitzer, Joseph J. McDonald, et al.. (2009). Structure based design of novel irreversible FAAH inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(20). 5970–5974. 9 indexed citations
12.
Meyers, Marvin J., et al.. (2009). Synthesis oftert-Butyl 6-Oxo-2-azaspiro[3.3]heptane-2-carboxylate. Organic Letters. 11(16). 3523–3525. 23 indexed citations
13.
Pelc, Matthew J., et al.. (2009). An Efficient and Regioselective Difluoromethylation of 3-Iodoindazole with Chlorodifluoromethane. Synlett. 2010(2). 219–222. 7 indexed citations
14.
Trujillo, John I., James R. Kiefer, Wei Huang, et al.. (2008). 2-(6-Phenyl-1H-indazol-3-yl)-1H-benzo[d]imidazoles: Design and synthesis of a potent and isoform selective PKC-ζ inhibitor. Bioorganic & Medicinal Chemistry Letters. 19(3). 908–911. 41 indexed citations
15.
Thorarensen, Atli, Donna L. Romero, Keith R. Marotti, et al.. (2007). Preparation of novel anthranilic acids as antibacterial agents. Extensive evaluation of alternative amide bioisosteres connecting the A- and the B-rings. Bioorganic & Medicinal Chemistry Letters. 17(10). 2823–2827. 14 indexed citations
16.
Stiff, Cory M., David R. Graber, Atli Thorarensen, et al.. (2007). Bacterial translation inhibitors, 1-acylindazol-3-ols as anthranilic acid mimics. Bioorganic & Medicinal Chemistry Letters. 18(23). 6293–6297. 9 indexed citations
17.
Li, Jianke, J. Craig Ruble, Cory M. Stiff, et al.. (2006). Preparation of novel antibacterial agents. Replacement of the central aromatic ring with heterocycles. Bioorganic & Medicinal Chemistry Letters. 17(8). 2347–2350. 14 indexed citations
18.
Thorarensen, Atli, et al.. (2001). Enols as Potent Antibacterial Agents. Bioorganic & Medicinal Chemistry Letters. 11(22). 2931–2934. 3 indexed citations
19.
Thorarensen, Atli, Michael J. Bohanon, Paul K. Tomich, et al.. (2001). 3-Arylpiperidines as potentiators of existing antibacterial agents. Bioorganic & Medicinal Chemistry Letters. 11(14). 1903–1906. 39 indexed citations
20.
Itami, Kenichiro, et al.. (1998). Chiral Benzoquinones as a New Class of Ligands for Asymmetric Catalysis:  Synthesis and Application to the Palladium(II)-Catalyzed 1,4-Dialkoxylation of 1,3-Dienes. The Journal of Organic Chemistry. 63(19). 6466–6471. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gregory P. Roth Breakdown of academic impact, for papers by Randall W. Hungate Breakdown of academic impact, for papers by R. M. Garbaccio Breakdown of academic impact, for papers by Mark E. Schnute Breakdown of academic impact, for papers by Todd C. Somers Breakdown of academic impact, for papers by Shyam Krishnan Breakdown of academic impact, for papers by Johannes D. Aebi Breakdown of academic impact, for papers by Jay Wrobel Breakdown of academic impact, for papers by J. T. Link Breakdown of academic impact, for papers by Nigel Vicker
Rankless by CCL
2026